Pharmacy Consumer Protection Act of 2005
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 4,105 other S bills in the 109th — cohort avg 35d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2006 · year_end · Pharmacy
Access to local Pharmacies, reimbursement rates - HR 1539, HR 1808, S 778, S 809/HR 1652, S 2264, S 109/HR 328, S 103/HR 314, HR 5762/S 2480
Client expense: Not reported · Firm income: $20,000
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
2006 · year_end · Pharmacy
H.R. 1652 Access to Legal Pharmaceuticals Act H.R. 1808 Safe Online Drug Act of 2005 H.R. 1815 National Defense Authorization Act for Fiscal Year 2006 – Pharmacy Program H.R. 4769 Prescription Drug Abuse Elimination Act of 2006 H.R. 5122 John Warner National Defense Authorization Act for Fiscal Year 2007 – Pharmacy Program H.R. 5280 Dextromethorphan Distribution Act of 2006 H.R. 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007 – Prescription Drug Importation H.R. 5441 Department of Homeland Security Appropriations Act, 2007 – Prescription Drug Importation S. 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S. 778 Pharmacy Consumer Protection Act of 2005 S. 809 Access to Legal Pharmaceuticals Act S. 2766 John Warner National Defense Authorization Act for Fiscal Year 2007 – Pharmacy Program S. 3807 Enhancing Drug Safety and Innovation Act of 2006 S. 3546 Dietary Supplement and Nonprescription Drug Consumer Protection Act Pharmacy Compounding Counterfeit Drugs Health Information Technology Implementation of the Combat Methamphetamine Epidemic Act of 2005 FDA Draft Compliance Policy Guide 160.900 on pedigree requirements under the Prescription Drug Marketing Act (PDMA) FDA Docket No. 2006N-0283 re: the proposed survey of physicians’ perceptions on the impact of early risk communication about medical products DEA Docket No. DEA-2911 re: retail sales of scheduled listed chemical products and self-certification of regulated sellers of scheduled listed chemical products CMS-1321-P re: proposed revisions to the payment policies under the physician fee schedule for calendar year 2007 DEA-287N re the issuing of multiple prescriptions for Schedule II Controlled Substances FDA Re: Draft Compliance Policy Guide 160.900 on pedigree requirements under the Prescription Drug Marketing Act Proposed revisions to the United States Pharmacopeia (USP) General Chapter <797> Pharmaceutical Compounding – Sterile Preparations. H.R. 1539 A bill to amend the Public Health Service Act with respect to the responsibilities of a pharmacy when a pharmacist employed by the pharmacy refuses to fill a valid prescription for a drug on the basis of religious beliefs or moral convictions, and for other purposes.
Client expense: $299,853 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2006 · year_end · Pharmacy
Access to local Pharmacies, reimbursement rates - HR 1539, HR 1808, S 778, S 809/HR 1652, S 2264, S 109/HR 328, S 103/HR 314, HR 5762/S 2480
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE